Healthcare Testing Services Market, by Service Type (Chemical Testing, Microbiological Testing, Toxicology Testing, Stability Testing, and Others), by Product Type (Anti-viral Drugs, HIV Drugs, Fertility Drugs, Anti-diabetic Drugs, Respiratory Drugs, Anti

Healthcare Testing Services Market, by Service Type (Chemical Testing, Microbiological Testing, Toxicology Testing, Stability Testing, and Others), by Product Type (Anti-viral Drugs, HIV Drugs, Fertility Drugs, Anti-diabetic Drugs, Respiratory Drugs, Anticoagulants, Medical Devices, Pharmaceutical Packaging, and Others), by Development Stage (Preclinical, Clinical, and Manufacturing), by End User (Pharmaceutical Industry, Contract Research Organization, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Healthcare testing services are invented, and developed in the laboratories. During pharmaceutical production and research and development, healthcare testing in labs is required at practically every stage including preclinical, clinical, and manufacturing. It is used to test raw materials and to perform an in-process quality control (IPQC) of dosage forms and finished products. Healthcare testing aids in assessing a medical product's safety, efficacy, stability, and dosage potency. Before releasing a product in the market, a healthcare testing laboratory can assist in testing to ensure that it is safe to use. Chemical testing, microbiological testing, toxicological testing, stability testing, and other services are just a few services that healthcare testing laboratories offer to guarantee the safety of medications and treatments.
Market Dynamics
Complex research and development procedures, stringent government regulations regarding product compliance, increasing product approvals by regulatory authorities, and launches of novel services and products are the major factors that are expected to drive the growth of the global healthcare testing services market over the forecast period.
Moreover, increasing number of funding initiatives by government and research organizations to provide funding to pharmaceutical and medical device manufacturing companies in order to develop drugs and diagnostic kits for the treatment of novel coronavirus, increasing research and development activities, and rising number of clinical trials owing to the COVID-19 outbreak are expected to create lucrative opportunities in the market. Many research organizations and government agencies are funding pharmaceutical and medical device manufacturing companies for the development of kits for diagnosis and drugs, and for the treatment of the novel coronavirus.
For instance, in April 2021, Moderna Inc., a clinical-stage biotechnology company, received US$ 483 million funding from the U.S. Biomedical Advanced Research and Development Authority (BARDA) for rapid development of Moderna’s mRNA vaccine candidate (mRNA-1273) against the SARS-CoV-2 coronavirus. The funding will be through Phase II and III clinical trials to United States Food and Drug Administration (FDA) licensure.

Key features of the study:
This report provides an in-depth analysis of the global healthcare testing services market, provides market size (US$ Mn), and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global healthcare testing services market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Eurofins Scientific, PPD, Inc., Microbac Laboratories, Inc., ARL Bio Pharma, Inc., Consumer Product Testing Company, Inc., Element Materials Technology Ltd., Intertek Group plc, DYNALABS LLC., ADPEN Laboratories, Inc., Moderna Inc., ZYUS Life Sciences Inc., PCI Pharma Services, Perfectus Biomed, Alcami Corporation Inc., SGS SA, Predictive Laboratories, Lasa Supergenerics Ltd, Roche Diagnostics India, National Jewish Health, and Parexel International Corporation, and Pfizer Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global healthcare testing services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global healthcare testing services market
Detailed Segmentation:
Global Healthcare Testing Services Market, By Service Type:
Chemical Testing
Microbiological Testing
Toxicology Testing
Stability Testing
Others
Global Healthcare Testing Services Market, By Product Type:
Anti-viral Drugs
HIV Drugs
Fertility Drugs
Anti-diabetic Drugs
Respiratory Drugs
Anticoagulants
Medical Devices
Pharmaceutical Packaging
Others
Global Healthcare Testing Services Market, By Development Stage:
Preclinical
Clinical
Manufacturing
Global Healthcare Testing Services Market, By End User:
Pharmaceutical Industry
Contract Research Organization
Others
Global Healthcare Testing Services Market, By Region:
North America
By Service Type
Chemical Testing
Microbiological Testing
Toxicology Testing
Stability Testing
Others
By Product Type
Anti-viral Drugs
HIV Drugs
Fertility Drugs
Anti-diabetic Drugs
Respiratory Drugs
Anticoagulants
Medical Devices
Pharmaceutical Packaging
Others
By Development Stage
Preclinical
Clinical
Manufacturing
By End User
Pharmaceutical Industry
Contract Research Organization
Others
By Country
U.S.
Canada
Latin America
By Service Type
Chemical Testing
Microbiological Testing
Toxicology Testing
Stability Testing
Others
By Product Type
Anti-viral Drugs
HIV Drugs
Fertility Drugs
Anti-diabetic Drugs
Respiratory Drugs
Anticoagulants
Medical Devices
Pharmaceutical Packaging
Others
By Development Stage
Preclinical
Clinical
Manufacturing
By End User
Pharmaceutical Industry
Contract Research Organization
Others
By Country
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Service Type
Chemical Testing
Microbiological Testing
Toxicology Testing
Stability Testing
Others
By Product Type
Anti-viral Drugs
HIV Drugs
Fertility Drugs
Anti-diabetic Drugs
Respiratory Drugs
Anticoagulants
Medical Devices
Pharmaceutical Packaging
Others
By Development Stage
Preclinical
Clinical
Manufacturing
By End User
Pharmaceutical Industry
Contract Research Organization
Others
By Country
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Service Type
Chemical Testing
Microbiological Testing
Toxicology Testing
Stability Testing
Others
By Product Type
Anti-viral Drugs
HIV Drugs
Fertility Drugs
Anti-diabetic Drugs
Respiratory Drugs
Anticoagulants
Medical Devices
Pharmaceutical Packaging
Others
By Development Stage
Preclinical
Clinical
Manufacturing
By End User
Pharmaceutical Industry
Contract Research Organization
Others
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Service Type
Chemical Testing
Microbiological Testing
Toxicology Testing
Stability Testing
Others
By Product Type
Anti-viral Drugs
HIV Drugs
Fertility Drugs
Anti-diabetic Drugs
Respiratory Drugs
Anticoagulants
Medical Devices
Pharmaceutical Packaging
Others
By Development Stage
Preclinical
Clinical
Manufacturing
By End User
Pharmaceutical Industry
Contract Research Organization
Others
By Country
GCC
Israel
Rest of Middle East
Africa
By Service Type
Chemical Testing
Microbiological Testing
Toxicology Testing
Stability Testing
Others
By Product Type
Anti-viral Drugs
HIV Drugs
Fertility Drugs
Anti-diabetic Drugs
Respiratory Drugs
Anticoagulants
Medical Devices
Pharmaceutical Packaging
Others
By Development Stage
Preclinical
Clinical
Manufacturing
By End User
Pharmaceutical Industry
Contract Research Organization
Others
By Country/Region
South Africa
Central Africa
North Africa
Company Profiles
Eurofins Scientific *
Company Overview
Material Portfolio
Financial Performance
Key Highlights
Market Strategies
PPD, Inc.
Microbac Laboratories, Inc.
ARL Bio Pharma, Inc.
Consumer Product Testing Company, Inc.
Element Materials Technology Ltd.
Intertek Group plc
DYNALABS LLC.
ADPEN Laboratories, Inc.
Moderna Inc.
ZYUS Life Sciences Inc.
PCI Pharma Services
Perfectus Biomed
Alcami Corporation Inc.
SGS SA
Predictive Laboratories
Lasa Supergenerics Ltd
Roche Diagnostics India
National Jewish Health
Parexel International Corporation
Pfizer Inc.
“*” marked represents similar segmentation in other categories in the respective section.